Investing Ideas
/
Danish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Danish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.

11 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
GUBRA Gubra	DKK 636.00	-4.5%	430.0%	DKK 10.4b	n/a	PS46.3x	n/a	0%
GMAB Genmab	DKK 1,509.50	-6.1%	-23.9%	DKK 95.9b	DKK 2,314.56	PE20.4x	E21.8%	n/a
STENO Stenocare	DKK 0.80	-4.2%	-68.1%	DKK 16.0m	n/a	PS7.2x	n/a	n/a
BAVA Bavarian Nordic	DKK 196.35	-2.6%	23.3%	DKK 15.4b	DKK 305.00	PE13.8x	E3.4%	n/a
ALK B ALK-Abelló	DKK 150.70	-1.5%	38.3%	DKK 33.3b	DKK 179.20	PE42.5x	E27.3%	0%
BIOPOR BioPorto	DKK 1.48	-4.9%	-30.8%	DKK 635.9m	DKK 3.00	PS18.2x	E-27.8%	n/a
STRAP Strategic Partners	DKK 890.00	1.2%	-31.5%	DKK 37.1m	n/a	PB2.3x	n/a	n/a
CHEMM ChemoMetec	DKK 522.00	-4.9%	41.2%	DKK 9.1b	DKK 545.00	PE66.7x	E17.5%	0.8%
HLUN B H. Lundbeck	DKK 40.26	-0.8%	16.8%	DKK 38.4b	DKK 50.15	PE14.9x	E7.4%	1.7%
ZEAL Zealand Pharma	DKK 713.50	-2.9%	61.3%	DKK 50.4b	DKK 1,007.64	PS655.7x	E39.1%	n/a
NOVO B Novo Nordisk	DKK 575.60	-9.0%	-21.4%	DKK 2.6t	DKK 830.68	PE27x	E13.5%	1.7%

Page 1 of 1